AIDS-RELATED KAPOSI SARCOMA
Clinical trials for AIDS-RELATED KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new AIDS-RELATED KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for AIDS-RELATED KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug aims to shrink kaposi sarcoma lesions
Disease control Not yet recruitingThis study tests a drug called nirogacestat in 28 people with Kaposi sarcoma (KS) that affects the skin. The drug blocks a protein that helps cancer cells grow, with the goal of shrinking tumors and preventing new ones. While current treatments can help, there is no cure for KS, …
Matched conditions: AIDS-RELATED KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New study tests cheaper chemo options for HIV cancer in africa
Disease control Not yet recruitingThis study compares two chemotherapy drugs, paclitaxel and pegylated liposomal doxorubicin, to see if they work similarly well for treating Kaposi sarcoma in people with HIV. The trial will enroll 130 participants in sub-Saharan Africa, giving each drug once every three weeks for…
Matched conditions: AIDS-RELATED KAPOSI SARCOMA
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated May 11, 2026 20:53 UTC